CGEM

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Cullinan Oncology LLC

NASDAQ | CGEM

8.72

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 20, 2025)

$499.19M

Market Cap

-

P/E Ratio

-3.32

EPS

$13.78

52 Week High

$5.68

52 Week Low

HEALTHCARE

Sector

CGEM Chart

Recent Chart
Price Action

CGEM Technicals

Tags:

CGEM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$306K
Total Revenue $0
Cost Of Revenue $306K
Costof Goods And Services Sold $306K
Operating Income -$197M
Selling General And Administrative $53M
Research And Development $143M
Operating Expenses $197M
Investment Income Net -
Net Interest Income $30M
Interest Income $30M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $306K
Income Before Tax -$167M
Income Tax Expense $117K
Interest And Debt Expense -
Net Income From Continuing Operations -$168M
Comprehensive Income Net Of Tax -
Ebit -$167M
Ebitda -$167M
Net Income -$167M

Revenue & Profitability

Earnings Performance

CGEM Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $622M
Total Current Assets $415M
Cash And Cash Equivalents At Carrying Value $83M
Cash And Short Term Investments $83M
Inventory -
Current Net Receivables $3M
Total Non Current Assets $207M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $204M
Short Term Investments $316M
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $31M
Total Current Liabilities $31M
Current Accounts Payable $1.7M
Deferred Revenue -
Current Debt -
Short Term Debt $1.3M
Total Non Current Liabilities $849K
Capital Lease Obligations $2.2M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.2M
Other Current Liabilities $28M
Other Non Current Liabilities -
Total Shareholder Equity $590M
Treasury Stock -
Retained Earnings -$368M
Common Stock $6K
Common Stock Shares Outstanding $54M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$145M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $306K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$136M
Cashflow From Financing $266M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$168M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$306K
Total Revenue $0
Cost Of Revenue $306K
Costof Goods And Services Sold $306K
Operating Income -$197M
Selling General And Administrative $53M
Research And Development $143M
Operating Expenses $197M
Investment Income Net -
Net Interest Income $30M
Interest Income $30M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $306K
Income Before Tax -$167M
Income Tax Expense $117K
Interest And Debt Expense -
Net Income From Continuing Operations -$168M
Comprehensive Income Net Of Tax -
Ebit -$167M
Ebitda -$167M
Net Income -$167M

CGEM News

CGEM Profile

Cullinan Oncology LLC Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Cullinan Oncology LLC is an innovative biopharmaceutical company based in Cambridge, Massachusetts, dedicated to advancing targeted oncology and immuno-oncology therapies to improve outcomes for cancer patients. With a robust pipeline of therapeutic candidates addressing significant unmet needs in oncology, Cullinan is at the forefront of transforming cancer treatment through cutting-edge science and strategic partnerships. The company's commitment to pioneering research positions it as a vital player in the dynamic landscape of oncology therapeutics, aiming to bring forth impactful solutions for various cancer types.

LPTX
+368.57%
$2.05
SOND
+79.15%
$0.16
BNKK
+19.70%
$0.17
NVDA
-3.15%
$180.64
IVP
+18.43%
$0.12
VHAI
-50.00%
$0.00
ONDS
-16.40%
$6.27
TSLA
-2.16%
$395.23
BYND
-9.80%
$0.88
WTO
-14.65%
$0.01
ASST
-6.40%
$0.98
PLUG
-0.52%
$1.89
SOFI
-6.77%
$24.91
INTC
-4.24%
$33.62
F
-3.79%
$12.41
SGBX
-37.06%
$3.82
CIFR
-0.41%
$14.56
GRAB
-6.21%
$4.98
VIVK
-9.58%
$0.11
BITF
0.00%
$2.60
AIIO
+41.76%
$0.78
NWTN
+41.76%
$0.78
PLTR
-5.84%
$155.74
DNN
-4.52%
$2.32
WULF
-5.47%
$11.56
ACHR
-8.03%
$6.87
NIO
-6.08%
$5.40
MNDR
+83.13%
$3.04
EXAS
+16.81%
$100.67
AXDX
-61.36%
$0.03
AMD
-7.84%
$206.02
AUID
+5.55%
$1.71
IREN
-5.14%
$43.47
GOOGL
-1.14%
$289.45
BMNR
-10.82%
$26.02
AAL
-0.72%
$12.24
MARA
-7.74%
$10.24
NOK
-2.65%
$5.87
DVLT
+8.75%
$1.74
RGTI
-10.44%
$22.80
SOUN
-2.92%
$11.29
PFE
-1.92%
$24.40
ADAP
-15.14%
$0.05
WMT
+6.46%
$107.11
AMZN
-2.49%
$217.14
MU
-10.86%
$201.37
WBD
-0.90%
$22.88
CHR
-7.57%
$0.05
AAPL
-0.86%
$266.25
RIVN
-0.40%
$14.66
SNAP
-3.11%
$7.78
RIG
-6.34%
$3.84
EOSE
+0.78%
$12.88
ABEV
-1.61%
$2.43
PLTD
+5.82%
$7.63
AZI
-18.11%
$0.06
BURU
-10.54%
$0.18
HOOD
-10.11%
$106.21
T
+0.98%
$25.52
UBER
-6.89%
$83.36
TLRY
-6.53%
$0.89
BBWI
-24.80%
$15.82
CRWV
-7.62%
$69.21
QBTS
-12.50%
$20.51
RMBL
+60.50%
$3.21
NFE
+25.86%
$1.46
LNW
-3.71%
$86.22
APLD
-7.44%
$21.37
RXRX
-4.46%
$3.85
ADD
-25.47%
$0.05
PCG
+0.76%
$15.84
SMCI
-6.43%
$31.56
CAN
-4.08%
$0.92
NFLX
-3.93%
$105.67
CYPH
0.00%
$2.94
BBD
-1.69%
$3.48
BAC
-1.96%
$51.00
BTBT
-5.09%
$2.05
IONZ
+28.40%
$6.42
BULL
+0.36%
$8.25
SRM
+53.27%
$10.30
GOOG
-1.02%
$289.98
NBIS
-10.97%
$84.64
QUBT
-11.15%
$10.27
NVVE
-15.67%
$0.16
BTG
-4.53%
$3.79
IONQ
-14.39%
$40.99
NVTS
-2.20%
$7.55
VZ
-1.04%
$40.76
PLTZ
+11.57%
$8.48
SMR
-11.50%
$18.70
LEN
+0.94%
$116.25
RZLV
-0.66%
$2.99
LAES
-7.86%
$3.63
VALE
-1.65%
$11.92
BTE
-0.62%
$3.16
CLSK
-4.30%
$9.78
BMNU
-22.39%
$5.37
CGC
-3.80%
$1.01
HBAN
-0.39%
$15.32
LPTX
+368.57%
$2.05
SOND
+79.15%
$0.16
BNKK
+19.70%
$0.17
NVDA
-3.15%
$180.64
IVP
+18.43%
$0.12
VHAI
-50.00%
$0.00
ONDS
-16.40%
$6.27
TSLA
-2.16%
$395.23
BYND
-9.80%
$0.88
WTO
-14.65%
$0.01
ASST
-6.40%
$0.98
PLUG
-0.52%
$1.89
SOFI
-6.77%
$24.91
INTC
-4.24%
$33.62
F
-3.79%
$12.41
SGBX
-37.06%
$3.82
CIFR
-0.41%
$14.56
GRAB
-6.21%
$4.98
VIVK
-9.58%
$0.11
BITF
0.00%
$2.60
AIIO
+41.76%
$0.78
NWTN
+41.76%
$0.78
PLTR
-5.84%
$155.74
DNN
-4.52%
$2.32
WULF
-5.47%
$11.56
ACHR
-8.03%
$6.87
NIO
-6.08%
$5.40
MNDR
+83.13%
$3.04
EXAS
+16.81%
$100.67
AXDX
-61.36%
$0.03
AMD
-7.84%
$206.02
AUID
+5.55%
$1.71
IREN
-5.14%
$43.47
GOOGL
-1.14%
$289.45
BMNR
-10.82%
$26.02
AAL
-0.72%
$12.24
MARA
-7.74%
$10.24
NOK
-2.65%
$5.87
DVLT
+8.75%
$1.74
RGTI
-10.44%
$22.80
SOUN
-2.92%
$11.29
PFE
-1.92%
$24.40
ADAP
-15.14%
$0.05
WMT
+6.46%
$107.11
AMZN
-2.49%
$217.14
MU
-10.86%
$201.37
WBD
-0.90%
$22.88
CHR
-7.57%
$0.05
AAPL
-0.86%
$266.25
RIVN
-0.40%
$14.66
SNAP
-3.11%
$7.78
RIG
-6.34%
$3.84
EOSE
+0.78%
$12.88
ABEV
-1.61%
$2.43
PLTD
+5.82%
$7.63
AZI
-18.11%
$0.06
BURU
-10.54%
$0.18
HOOD
-10.11%
$106.21
T
+0.98%
$25.52
UBER
-6.89%
$83.36
TLRY
-6.53%
$0.89
BBWI
-24.80%
$15.82
CRWV
-7.62%
$69.21
QBTS
-12.50%
$20.51
RMBL
+60.50%
$3.21
NFE
+25.86%
$1.46
LNW
-3.71%
$86.22
APLD
-7.44%
$21.37
RXRX
-4.46%
$3.85
ADD
-25.47%
$0.05
PCG
+0.76%
$15.84
SMCI
-6.43%
$31.56
CAN
-4.08%
$0.92
NFLX
-3.93%
$105.67
CYPH
0.00%
$2.94
BBD
-1.69%
$3.48
BAC
-1.96%
$51.00
BTBT
-5.09%
$2.05
IONZ
+28.40%
$6.42
BULL
+0.36%
$8.25
SRM
+53.27%
$10.30
GOOG
-1.02%
$289.98
NBIS
-10.97%
$84.64
QUBT
-11.15%
$10.27
NVVE
-15.67%
$0.16
BTG
-4.53%
$3.79
IONQ
-14.39%
$40.99
NVTS
-2.20%
$7.55
VZ
-1.04%
$40.76
PLTZ
+11.57%
$8.48
SMR
-11.50%
$18.70
LEN
+0.94%
$116.25
RZLV
-0.66%
$2.99
LAES
-7.86%
$3.63
VALE
-1.65%
$11.92
BTE
-0.62%
$3.16
CLSK
-4.30%
$9.78
BMNU
-22.39%
$5.37
CGC
-3.80%
$1.01
HBAN
-0.39%
$15.32
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.